cyclosporine
cyclosporine is listed in the FDA National Drug Code directory with 31 NDC codes, marketed under brand names including Cyclosporine, RESTASIS, Neoral. Available dosage forms: emulsion, injection, capsule, liquid filled, solution, solution/ drops.
Drug Details
- Generic Name
- cyclosporine
- Brand Names
- Cyclosporine, RESTASIS, Neoral, Sandimmune, Verkazia, CYCLOSPORINE, CEQUA, Restasis MultiDose
- Application Number
- ANDA209811
- Sponsor
- Devatis Inc.
- NDC Codes
- 31
- Dosage Forms
- EMULSION, INJECTION, CAPSULE, LIQUID FILLED, SOLUTION, SOLUTION/ DROPS
- Routes
- OPHTHALMIC, ORAL, INTRAVENOUS, TOPICAL
- Active Ingredients
- CYCLOSPORINE
Indications and Usage
1 INDICATIONS AND USAGE Cyclosporine ophthalmic emulsion, 0.05% is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. Cyclosporine ophthalmic emulsion, 0.05% is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. ( 1 )